Ducray Neoptide Hair Loss Treatment 3X30ml

4.7 (REVIEWS 3)
Brand: DUCRAY SKU: 110313
  • Ducray Neoptide Women Anti-Hair Loss Treatment is specially designed to curb female chronic hair loss and stimulate hair growth. It works directly on the hair follicle to stimulate the anagen phase (hair growth phase). Thanks to its light texture, it penetrates easily, it can be used daily and does not make hair fatty
  • Tested under dermatological control
  • Made in France

Read More

AED367.50
AED367.50 (VAT Incl.)
DUCRAY
DELIVER TO
IN CHANGE
  • Free Delivery For all orders over AED 29
  • Easy Return Easy return and refund
  • Secure Payments Payment Method
  • 24/7 Support Dedicated Support
  • Ducray Neoptide Women Anti-Hair Loss Treatment is specially designed to curb female chronic hair loss and stimulate hair growth. It works directly on the hair follicle to stimulate the anagen phase (hair growth phase). Thanks to its light texture, it penetrates easily, it can be used daily and does not make hair fatty
  • Tested under dermatological control
  • Made in France

This stimulating lotion curbs hair loss and stimulates hair growth with its targeted action on the hair growth phase in women. It's light texture facilitates daily use without any greasy effect.

Directions of Use:

Apply once a day, preferably in the evening, directly throughout the dry or wet scalp.
Massage until absorbed.
Do not rinse.
Do not apply to injured skin.
Use in well-ventilated areas.
Keep out of reach of children
IndicationChronic hair loss.
 
Ingredients:
 
Water (Aqua), SD Alcohol 39-C (Alcohol Denat.), Hexylene Glycol, Niacinamide, Acetyl Tetrapeptide-2, Artemia Extract, Benzyl Salicylate, Butylphenyl Methylpropional, Citronellol, Dextran, Parfum (Fragrance), Glycerin, Hexyl Cinnamal, Limonene, Linalool, Mentha Viridis (Spearmint) Leaf Oil (Mentha Viridis Oil), Ruscus Aculeatus Root Extract.

 

SKU: 110313

Product Rating

4.7/5

4.7

Based on 3 Ratings.

5
2
4
1
3
0
2
0
1
0

Reviews (3 of 3)

5304494000033909

5
Sep 15, 2022
No comment

Mary Wanees

4
Jun 19, 2022
No comment

rashed alnaqbi

5
Jun 3, 2022
No comment